| Seizure | 111 |
| Off label use | 44 |
| Hyponatraemia | 41 |
| Drug ineffective | 32 |
| Drug dose titration not performed | 22 |
| Rash | 17 |
| Dizziness | 16 |
| Somnolence | 16 |
| Pruritus | 13 |
| Drug interaction | 12 |
| Depression | 11 |
| Nausea | 11 |
| Suicidal ideation | 11 |
| Generalised tonic-clonic seizure | 10 |
| Overdose | 10 |
| Anxiety | 9 |
| Blood sodium decreased | 9 |
| Dyspnoea | 9 |
| Headache | 9 |
| Vomiting | 9 |
| Ataxia | 8 |
| Drug reaction with eosinophilia and systemic symptoms | 8 |
| Epilepsy | 8 |
| Fatigue | 8 |
| Leukopenia | 8 |
| Agitation | 7 |
| Confusional state | 7 |
| Pain | 7 |
| Balance disorder | 6 |
| Condition aggravated | 6 |
| Death | 6 |
| Fall | 6 |
| Gamma-glutamyltransferase increased | 6 |
| Irritability | 6 |
| Rash maculo-papular | 6 |
| Bradycardia | 5 |
| Inappropriate schedule of drug administration | 5 |
| Insomnia | 5 |
| Labelled drug-drug interaction medication error | 5 |
| Loss of consciousness | 5 |
| Malaise | 5 |
| Neutropenia | 5 |
| Partial seizures | 5 |
| Product use in unapproved indication | 5 |
| Simple partial seizures | 5 |
| Swelling face | 5 |
| Tremor | 5 |
| Vertigo | 5 |
| Abdominal pain | 4 |
| Aggression | 4 |
| Aphasia | 4 |
| Cerebrovascular accident | 4 |
| Cognitive disorder | 4 |
| Decreased appetite | 4 |
| Diplopia | 4 |
| Gait disturbance | 4 |
| Hyponatraemic seizure | 4 |
| Paraesthesia | 4 |
| Prescribed overdose | 4 |
| Product dose omission issue | 4 |
| Suicide attempt | 4 |
| Thrombocytopenia | 4 |
| Underdose | 4 |
| Abortion spontaneous | 3 |
| Amnesia | 3 |
| Atrioventricular block complete | 3 |
| Chills | 3 |
| Cholestasis | 3 |
| Congenital anomaly | 3 |
| Coordination abnormal | 3 |
| Disturbance in attention | 3 |
| Dysphagia | 3 |
| Memory impairment | 3 |
| Nervousness | 3 |
| No adverse event | 3 |
| Peripheral swelling | 3 |
| Petit mal epilepsy | 3 |
| Product use issue | 3 |
| Status epilepticus | 3 |
| Tinnitus | 3 |
| Toxic epidermal necrolysis | 3 |
| Unresponsive to stimuli | 3 |
| Vision blurred | 3 |
| Weight fluctuation | 3 |
| Weight increased | 3 |
| Abnormal behaviour | 2 |
| Anger | 2 |
| Angioedema | 2 |
| Asthenia | 2 |
| Bradyphrenia | 2 |
| Cardiac arrest | 2 |
| Cardio-respiratory arrest | 2 |
| Clumsiness | 2 |
| Coma | 2 |
| Convulsion | 2 |
| Cough | 2 |
| Cytopenia | 2 |
| Delirium | 2 |
| Dermatitis exfoliative | 2 |
| Diarrhoea | 2 |
| Drug dose omission | 2 |
| Drug intolerance | 2 |
| Eosinophilia | 2 |
| Erythema | 2 |
| Exposure during pregnancy | 2 |
| Feeling abnormal | 2 |
| Focal dyscognitive seizures | 2 |
| Foetal exposure during pregnancy | 2 |
| Hallucination | 2 |
| Hallucination, auditory | 2 |
| Hallucination, visual | 2 |
| Hepatic cytolysis | 2 |
| Hepatocellular injury | 2 |
| Hypersensitivity | 2 |
| Hypertonia | 2 |
| Hypoaesthesia | 2 |
| Hypochloraemia | 2 |
| Hypokalaemia | 2 |
| Lacrimation increased | 2 |
| Liver function test abnormal | 2 |
| Lymphadenopathy | 2 |
| Mood altered | 2 |
| Muscle rigidity | 2 |
| Muscle twitching | 2 |
| Myoclonus | 2 |
| Neck pain | 2 |
| Nocturia | 2 |
| Pancreatitis | 2 |
| Pancreatitis acute | 2 |
| Pharyngeal oedema | 2 |
| Pollakiuria | 2 |
| Pregnancy | 2 |
| Product dose omission | 2 |
| Pulmonary embolism | 2 |
| Pyrexia | 2 |
| Road traffic accident | 2 |
| Salivary hypersecretion | 2 |
| Seizure cluster | 2 |
| Skin lesion | 2 |
| Sleep disorder | 2 |
| Stress | 2 |
| Sudden unexplained death in epilepsy | 2 |
| Swelling | 2 |
| Tachycardia | 2 |
| Therapeutic product effect incomplete | 2 |
| Therapy cessation | 2 |
| Treatment noncompliance | 2 |
| Urinary incontinence | 2 |
| Wrong technique in product usage process | 2 |
| Abdominal pain lower | 1 |
| Accidental overdose | 1 |
| Acne | 1 |
| Acute pulmonary oedema | 1 |
| Adams-Stokes syndrome | 1 |
| Adrenal insufficiency | 1 |
| Agranulocytosis | 1 |
| Akathisia | 1 |
| Alcohol withdrawal syndrome | 1 |
| Alveolitis allergic | 1 |
| Amylase increased | 1 |
| Anaphylactic reaction | 1 |
| Aneurysm | 1 |
| Ankle fracture | 1 |
| Anticonvulsant drug level below therapeutic | 1 |
| Anticonvulsant drug level decreased | 1 |
| Anticonvulsant drug level increased | 1 |
| Anxiety disorder | 1 |
| Aortic aneurysm rupture | 1 |
| Arrhythmia | 1 |
| Arthralgia | 1 |
| Aspartate aminotransferase increased | 1 |
| Asterixis | 1 |
| Asthma | 1 |
| Atonic seizures | 1 |
| Attention deficit/hyperactivity disorder | 1 |
| Back pain | 1 |
| Behaviour disorder | 1 |
| Blindness unilateral | 1 |
| Blister | 1 |
| Blood glucose increased | 1 |
| Blood sodium increased | 1 |
| Blood urea decreased | 1 |
| Blood urea nitrogen/creatinine ratio decreased | 1 |
| Bone marrow failure | 1 |
| Bradyarrhythmia | 1 |
| Brain operation | 1 |
| Brief psychotic disorder, with postpartum onset | 1 |
| C-reactive protein increased | 1 |
| Cardiac failure | 1 |
| Cerebellar atrophy | 1 |
| Cerebellar syndrome | 1 |
| Change of bowel habit | 1 |
| Chest pain | 1 |
| Choking sensation | 1 |
| Clonus | 1 |
| Completed suicide | 1 |
| Complex partial seizures | 1 |
| Conjoined twins | 1 |
| Constipation | 1 |
| Continuous haemodiafiltration | 1 |
| Crying | 1 |
| Cutaneous vasculitis | 1 |
| Cyanosis | 1 |
| Cytogenetic abnormality | 1 |
| Cytotoxic lesions of corpus callosum | 1 |
| Daydreaming | 1 |
| Decreased interest | 1 |
| Deep vein thrombosis | 1 |
| Delusion | 1 |
| Dementia | 1 |
| Demyelination | 1 |
| Dental caries | 1 |
| Depressed level of consciousness | 1 |
| Depressive symptom | 1 |
| Dermatitis allergic | 1 |
| Diabetes mellitus | 1 |
| Disability | 1 |
| Discomfort | 1 |
| Dissociation | 1 |
| Drowning | 1 |
| Drug administration error | 1 |
| Drug effective for unapproved indication | 1 |
| Drug resistance | 1 |
| Drug screen false positive | 1 |
| Drug screen positive | 1 |
| Dry mouth | 1 |
| Dysarthria | 1 |
| Dyspepsia | 1 |
| Dysstasia | 1 |
| Dysuria | 1 |
| Ear discomfort | 1 |
| Ear pain | 1 |
| Eczema | 1 |
| Electrocardiogram QT prolonged | 1 |
| Enanthema | 1 |
| Encephalopathy | 1 |
| Endotracheal intubation | 1 |
| Eosinophil count increased | 1 |
| Erythema multiforme | 1 |
| Extra dose administered | 1 |
| Eye pain | 1 |
| Eyelid ptosis | 1 |
| Facial pain | 1 |
| Faecaloma | 1 |
| Family stress | 1 |
| Feeling drunk | 1 |
| Femoral neck fracture | 1 |
| Flatulence | 1 |
| Fluid intake reduced | 1 |
| Fontanelle bulging | 1 |
| Frustration tolerance decreased | 1 |
| Gastrointestinal tube insertion | 1 |
| Gaze palsy | 1 |
| General physical health deterioration | 1 |
| Generalised erythema | 1 |
| Gestational diabetes | 1 |
| Haematochezia | 1 |
| Haemorrhage | 1 |
| Hashimoto's encephalopathy | 1 |
| Heart rate increased | 1 |
| Hemiparesis | 1 |
| Hepatic enzyme increased | 1 |
| Hepatic failure | 1 |
| Hepatitis | 1 |
| Hepatitis C | 1 |
| Hepatitis C RNA | 1 |
| Herpes zoster | 1 |
| Hirsutism | 1 |
| Hypercalcaemia | 1 |
| Hyperlipidaemia | 1 |
| Hypersomnia | 1 |
| Hypertension | 1 |
| Hypertensive crisis | 1 |
| Hypertransaminasaemia | 1 |
| Hyponatraemic encephalopathy | 1 |
| Hypospadias | 1 |
| Hypothyroidism | 1 |
| Hypovolaemia | 1 |
| Illness | 1 |
| Impulse-control disorder | 1 |
| Inappropriate antidiuretic hormone secretion | 1 |
| Incoherent | 1 |
| Incorrect dosage administered | 1 |
| Incorrect route of drug administration | 1 |
| Infection | 1 |
| Initial insomnia | 1 |
| Intentional product use issue | 1 |
| Intentional self-injury | 1 |
| Intentional underdose | 1 |
| Intercepted drug administration error | 1 |
| Jugular vein thrombosis | 1 |
| Leg amputation | 1 |
| Libido decreased | 1 |
| Lip dry | 1 |
| Lip swelling | 1 |
| Lipase increased | 1 |
| Livedo reticularis | 1 |
| Liver disorder | 1 |
| Liver function test increased | 1 |
| Localised oedema | 1 |
| Logorrhoea | 1 |
| Lupus-like syndrome | 1 |
| Madarosis | 1 |
| Maternal exposure during breast feeding | 1 |
| Maternal exposure during pregnancy | 1 |
| Mental disorder | 1 |
| Mental impairment | 1 |
| Mental status changes | 1 |
| Metabolic acidosis | 1 |
| Metamorphopsia | 1 |
| Migraine | 1 |
| Mood swings | 1 |
| Multimorbidity | 1 |
| Multiple organ dysfunction syndrome | 1 |
| Multiple-drug resistance | 1 |
| Muscle tightness | 1 |
| Muscular weakness | 1 |
| Myoclonic epilepsy | 1 |
| Necrosis | 1 |
| Nephrolithiasis | 1 |
| Nephrotic syndrome | 1 |
| Neutrophil count decreased | 1 |
| Nodal arrhythmia | 1 |
| Normochromic normocytic anaemia | 1 |
| Occipital neuralgia | 1 |
| Ocular hyperaemia | 1 |
| Odynophagia | 1 |
| Oedema | 1 |
| Oral mucosal blistering | 1 |
| Oropharyngeal pain | 1 |
| Palatal oedema | 1 |
| Palpitations | 1 |
| Pancytopenia | 1 |
| Panic attack | 1 |
| Parathyroid tumour benign | 1 |
| Parotid gland enlargement | 1 |
| Pericardial effusion | 1 |
| Pharyngeal swelling | 1 |
| Pharyngitis | 1 |
| Physical assault | 1 |
| Pigmentation disorder | 1 |
| Pleural effusion | 1 |
| Pneumonia | 1 |
| Pneumonia staphylococcal | 1 |
| Polycystic ovaries | 1 |
| Polydactyly | 1 |
| Porphyria acute | 1 |
| Postictal psychosis | 1 |
| Postictal state | 1 |
| Potentiating drug interaction | 1 |
| Prescription drug used without a prescription | 1 |
| Presyncope | 1 |
| Procedural haemorrhage | 1 |
| Product availability issue | 1 |
| Product label issue | 1 |
| Product physical issue | 1 |
| Product quality issue | 1 |
| Product storage error | 1 |
| Product substitution issue | 1 |
| Productive cough | 1 |
| Prostate cancer | 1 |
| Proteinuria | 1 |
| Prothrombin time prolonged | 1 |
| Psychomotor hyperactivity | 1 |
| Pupillary reflex impaired | 1 |
| Rash erythematous | 1 |
| Rash macular | 1 |
| Rebound effect | 1 |
| Renal impairment | 1 |
| Respiratory disorder | 1 |
| Respiratory failure | 1 |
| Respiratory tract congestion | 1 |
| Restlessness | 1 |
| Resuscitation | 1 |
| Rheumatoid arthritis | 1 |
| Rhinitis | 1 |
| Rhinorrhoea | 1 |
| Sedation | 1 |
| Self-injurious ideation | 1 |
| Sepsis | 1 |
| Sinoatrial block | 1 |
| Sinus bradycardia | 1 |
| Skeletal injury | 1 |
| Skin abrasion | 1 |
| Skin discolouration | 1 |
| Skin exfoliation | 1 |
| Skin oedema | 1 |
| Skull fracture | 1 |
| Slow response to stimuli | 1 |
| Slow speech | 1 |
| Spinal fracture | 1 |
| Stevens-Johnson syndrome | 1 |
| Subdural haematoma | 1 |
| Supraventricular tachycardia | 1 |
| Syncope | 1 |
| Temperature intolerance | 1 |
| Therapeutic product effect increased | 1 |
| Therapeutic response unexpected | 1 |
| Therapy interrupted | 1 |
| Thirst decreased | 1 |
| Throat irritation | 1 |
| Thrombocytopenic purpura | 1 |
| Thyroid disorder | 1 |
| Tonic posturing | 1 |
| Tooth erosion | 1 |
| Tooth loss | 1 |
| Toxic optic neuropathy | 1 |
| Toxic skin eruption | 1 |
| Toxicologic test abnormal | 1 |
| Transaminases increased | 1 |
| Trigeminal neuralgia | 1 |
| Tuberculosis | 1 |
| Urinary retention | 1 |
| Urine abnormality | 1 |
| Ventricular tachycardia | 1 |
| Visual acuity reduced | 1 |
| Visual field defect | 1 |
| Visual impairment | 1 |
| Vital capacity decreased | 1 |
| Weight decreased | 1 |
| White blood cell count decreased | 1 |
| Withdrawal syndrome | 1 |
| Wrong dose | 1 |
| Wrong schedule | 1 |
| Yawning | 1 |
